Topical Calcineurin Inhibitors Not Tied to Skin Cancer

THURSDAY, Aug. 27, 2020 -- There is no association between use of topical calcineurin inhibitors (TCIs) for the treatment of atopic dermatitis (AD) and an increased risk for skin cancer, according to a study published online Aug. 12 in JAMA...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news